Joe Q Zhou

A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models

Mohammad Tabrizi, Steve Emery, Corinne Reimer, 2010, Molecular Cancer Therapeutics.